Crossmark Global Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Crossmark Global Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-11,441	Closed	-$360K	–	1282
2026 Q2	$360K	Hold	11,441	–	–	﹤0.01%	996
2026 Q1	$283K	Hold	11,441	–	–	﹤0.01%	1050
2025 Q4	$267K	Buy	+11,441	New	+$255K	﹤0.01%	1075

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Crossmark Global Holdings's CPRX Position: Q3 2026 in Review

Crossmark Global Holdings sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 11,441 shares — an estimated $360K sold.

Crossmark Global Holdings first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $360K in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

Crossmark Global Holdings reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Crossmark Global Holdings sold 11,441 Catalyst Pharmaceutical shares in Q3 2026, an estimated $360K.
Crossmark Global Holdings first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
Crossmark Global Holdings's Catalyst Pharmaceutical position peaked at $360K in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.